18 Nov 2017 | 7:52 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
903.85
9.31
(1.04 %)
17 Nov 2017 | 03:41 PM
Change company
  • Open (Rs)
    907.40
  • Prev. close (Rs.)
    894.55
  • High (Rs.)
    920.00
  • Low (Rs.)
    900.15
  • 52W H (Rs.)
    1,080.00
  • 52W L (Rs.)
    545.00
  • Volume
    8972
  • MCap (Rs in Cr.)
    15,754.83
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
27.88
Operating Margin (%)
33.82
Gross Profit Margin (%)
31.13
Net Profit Margin (%)
24.05
Total Debt/Equity
0.13
Dividend payout Ratio (Net Profit)
29.13
Earning Retention Ratio
70.80

News

03 Nov 2017 - 12:22:00-Drug maker Natco Pharma said that its marketing partner Alvogen has received the final approval fir...
02 Nov 2017 - 16:49:00-Natco Pharma today reported a 27.49 per cent rise in consolidated net profit to Rs 84...
05 Oct 2017 - 13:09:00-Natco Pharma's marketing partner Mylan has launched generic Glatiramer Acetate injection used in...
04 Oct 2017 - 12:40:00-Shares of Natco Pharma jumped 20 per cent on the Bombay Stock Exchange after the US Food and Drug Ad...

Announcements

04-Nov-2017
Natco Pharma - Investor Presentation
04-Nov-2017
Natco Pharma - Press Release
03-Nov-2017
Natco Pharma - Limited Review Report
03-Nov-2017
Natco Pharma - Press Release
03-Nov-2017
Natco Pharma - Press Release / Media Release

Religare Research

17 Nov 2017 | 06:00 PM
Karnataka Bank (KTK) is one of the oldest private sector banks with a strong regional presence in t...
17 Nov 2017 | 06:00 PM
It was a difficult week for the traders as the domestic benchmark index, Nifty, traded volatile and ...
17 Nov 2017 | 01:57 PM
Sutlej Textiles Industries Ltd (STIL) reported subdued numbers for Q2FY18. While net revenue grew by...
17 Nov 2017 | 10:38 AM
Gold steadied, investors weighed U.S. rate moves against fiscal outlook Dollar weakens on report Tru...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 33.53 0.57
4,00,000 90.05 141.69 0.55
4,00,000 90.05 148.65 0.55
4,00,000 90.05 54.09 0.54
1,60,000 35.89 93.94 0.91

Shareholding Pattern

       
Promotors51.19%
Mutual Funds/UTI4.94%
FI/Banks0.49%
Insurance0.49%
FII21.52%
Government0.00%
Others3.27%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,942.00(1.53)
3280
 Sanofi India Ltd.
4,497.40(0.91)
3325
 Piramal Enterprises Ltd.
2,595.40(0.77)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,511.40(-0.90)
3317

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-81.95131.25-53.75
NIFTY(S&P CNX)49.15379.45757.85
BSE SENSEX733.641,547.342,684.03
BSE 500207.29782.841,184.03

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar